牛牛AI助手已提取核心信息
Jessica Edgar Morris, the Chief Operating Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was involved in a transaction on February 27, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Morris is closely watched by investors for insights into executive confidence and potential future performance of the company's stock.
Jessica Edgar Morris, the Chief Operating Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was involved in a transaction on February 27, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Morris is closely watched by investors for insights into executive confidence and potential future performance of the company's stock.
Tonix Pharmicals Holding Corp.（TNXP）首席运营官杰西卡·埃德加·莫里斯于2024年2月27日参与了一笔交易。该交易的具体细节，包括行动类型、状态、股票数量、股票性质、交易价格和交易后持有量，未在公告中披露。作为公司的主要高管，莫里斯的任何交易活动都受到投资者的密切关注，以深入了解公司股票的高管信心和潜在的未来表现。
Tonix Pharmicals Holding Corp.（TNXP）首席运营官杰西卡·埃德加·莫里斯于2024年2月27日参与了一笔交易。该交易的具体细节，包括行动类型、状态、股票数量、股票性质、交易价格和交易后持有量，未在公告中披露。作为公司的主要高管，莫里斯的任何交易活动都受到投资者的密切关注，以深入了解公司股票的高管信心和潜在的未来表现。
有用
没用